A Novel TRG-N Prognostic Classification System for Esophageal Cancer Undergoing Neoadjuvant Therapy Followed by Esophagectomy
Authors:
- Jingpu WangJWJingpu Wang
- Zhouqiao WuZWZhouqiao Wu
- Rob H.A. VerhoevenRVRob H.A. Verhoeven
- Lucas GoenseLGLucas Goense
- Nadia Haj MohammadNMNadia Haj Mohammad
- Stella MookSMStella Mook
- Peter S.N. van RossumPRPeter S.N. van Rossum
- Marije SlingerlandMSMarije Slingerland
- Jan Erik FreundJFJan Erik Freund
- Jelle P. RuurdaJRJelle P. Ruurda
- Richard van HillegersbergRHRichard van Hillegersberg
Open Access
- 23 September 2025
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 282 (5) , 837-844
Abstract
Objective: To develop a new prognostic classification system centered on tumor regression grade (TRG) and ypN stage that can effectively stratify overall survival (OS) of esophageal cancer patients undergoing neoadjuvant therapy (NAT) followed by R0 esophagectomy. Summary Background Data: Although the prognostic value of combining TRG and ypN stage has been demonstrated, a prognostic classification system integrating these factors, trained using large-scale data, remains unavailable. Methods: Data from the Netherlands Cancer Registry (2015–2022) were analyzed. A new TRG-N prognostic classification system for OS was developed by grouping patients based on cN stage, ypN stage, and TRG. The prognostic performance of the TRG-N classification was compared with the 8th edition AJCC ypTNM classification using 4 comparative metrics (Log-rank χ², Linear trend χ², Akaike’s Information Criterion [AIC], and C-index). Results: A total of 3,193 patients were included. Among patients with adenocarcinoma, the TRG-N classification showed superior Linear trend χ² and AIC to the ypTNM classification. However, the Log-rank χ² of the TRG-N classification was inferior to that of the ypTNM classification, with no significant difference in the C-index (P-value=0.206) between the two systems. Among patients with squamous cell carcinoma, the TRG-N classification significantly outperformed the ypTNM classification in Log-rank χ², Linear trend χ², AIC, and C-index (P-value=0.018). Conclusion: The TRG-N classification demonstrated comparable prognostic performance to the AJCC ypTNM classification for esophageal adenocarcinoma but showed superior prognostic value for esophageal squamous cell carcinoma, making it a potentially more effective tool for risk stratification in esophageal cancer patients.Keywords
This publication has 27 references indexed in Scilit:
- The Epidemiology of Esophageal AdenocarcinomaGastroenterology, 2018
- Impact of diagnosis-to-treatment waiting time on survival in esophageal cancer patients – A population-based study in The NetherlandsEuropean Journal of Surgical Oncology, 2017
- Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging PrimerJournal of Thoracic Oncology, 2017
- Prognostic significance of tumor regression grade for patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy followed by surgeryJournal of Surgical Oncology, 2016
- Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trialThe Lancet Oncology, 2015
- Tumor Regression Grading of Gastrointestinal Carcinomas after Neoadjuvant TreatmentFrontiers in Oncology, 2013
- Preoperative Chemoradiotherapy for Esophageal or Junctional CancerNew England Journal of Medicine, 2012
- Gastric Cancer Risk in Patients With Premalignant Gastric Lesions: A Nationwide Cohort Study in the NetherlandsGastroenterology, 2008
- Histomorphologic Tumor Regression and Lymph Node Metastases Determine Prognosis Following Neoadjuvant Radiochemotherapy for Esophageal CancerAnnals of Surgery, 2005
- Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlationsCancer, 1994